Noema Pharma
Operator of a biotechnology company intended to address the disabling symptoms in orphan conditions of the central nervous system. The company offers novel therapies for conditions affecting the nervo...
Valuation
$228.8M
Market implied
Share Price
N/A
Total Raised
$209.8M
Last Round
N/A